United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need

  • Frequent, COVID-19 rapid tests could spur end of pandemic, make stay-at-home orders possible
  • Countries turning to faster, more affordable tests to curb virus spread, enable economic recovery
  • United Medical poised to capitalize on surging demand for rapid testing

Frequent rapid testing could curb COVID-19 within weeks, a recent study published by the University of Colorado Boulder and Harvard University shows (https://ibn.fm/qmy42). Factors such as test turnaround-time and frequency are key in limiting the spread of the virus, making rapid tests one of the key tools for managing the virus outbreak. As such, the rapid tests are increasingly used in countries around the world to enable economic revival and help societies go back to normal. United Medical Equipment Business Solutions Network (“UME”), a company offering both antigen and antibody rapid COVID-19 test kits, stands ready to respond to the growing need for this critical public health tool.

The study demonstrates that testing half of the population weekly with inexpensive, rapid-turnaround COVID-19 tests could accelerate virus elimination within weeks. Despite their lower sensitivity compared to gold-standard clinical tests, these rapid kits could enable an approach based on “personalized stay-at-home orders,” which would remove the need for mass closures of hospitality outlets, retail stores and schools, the study notes. For example, in a hypothetical scenario involving a city with 4% of individuals already infected, rapid testing three out of four people every three days would reduce the number ultimately infected by as much as 88%. This would be sufficient to push the epidemic toward extinction within six weeks, authors claim.

The research was published against the backdrop of significant commercial and academic effort to develop low-cost, rapid tests that could be deployed in large public settings or commercialized for do-it-yourself use. These tests could enable the comeback of public events, such as sports competitions, concerts and travel, which are currently almost completely shut down because of their high risk of virus spread. Combined with the use of masks, rapid testing of people involved in these activities could bring back to life almost-decimated sectors while minimizing the spread risk at the same time.

Several countries have already begun countrywide testing, while the new U.S. administration has named rapid testing as a priority. As the countries are turning to faster, cheaper tests to accelerate the COVID-19 public health response, demand for these products is growing. As a supplier of rapid COVID-19 test kits, United Medical is poised to capitalize on the surging need for rapid testing. Designed to test workers without symptoms as well as those who show certain symptoms or have been in close contact with someone who has been infected, these test kits could be the answer to large-scale testing needs in the future. Capable of quickly and affordably identifying individuals who are most likely to be actively infectious, these products will continue to be a valuable addition to the tool kit in the fight against COVID-19. Testing is most likely to remain an important part of health protocols even after the widespread rollout of the vaccines, securing the sizeable market for rapid testing kits in the future.

For more information about United Medical as well as its Medication Management app, visit the www.UnitedMedSolutions.com and www.MedicationManagement.app.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Archives

Select A Month

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050